Sanofi and GSK to seek authorization for COVID vaccine
$ 20.99 · 5 (478) · In stock
Recon: Sanofi, GSK to seek approval for COVID vaccine candidate; Novavax begins shipping vaccines to EU states
Sanofi-GSK COVID-19 Booster More Protective Against Omicron Than Pfizer-BioNTech
EMA starts review of Sanofi-GSK COVID vaccine application
A closer look at the vaccines Canada is betting on to stem the spread of COVID-19
New vaccine demonstrates 100% efficacy against severe COVID, hospitalizations - CBS New York
Special report on EU COVID-19 vaccine procurement
COVID vaccine from Sanofi and GSK is delayed, triggering uncertainty ahead of Europe's mass inoculation campaigns - MarketWatch
Sanofi-GSK Covid-19 vaccine triggers immune responses in trial
Sanofi, GSK post 58% efficacy in omicron-affected COVID-19 vaccine trial, teeing up race to regulators
Sanofi and GSK plan to ask regulators to authorize their COVID-19 vaccine - ABC News